Missing JNU student Najeeb Ahmed in Aligarh, claims suspicious letter

November 19, 2016

New Delhi, Nov 19: A ‘mysterious letter’ delivered at Jawaharlal Nehru University four days ago claims that the missing JNU student Najeeb Ahmad was held captive in a village in Aligarh, reportedly.

najeebAccording to media reports, the Delhi Police is probing the letter that was apparently sent by a woman in Aligarh. She claimed to have important information about Najeeb.

The letter that was addressed to ‘Ahmed’ was received by the hostel’s president, reportedly. The president however, gave the letter to Ahmed’s mother ‘Fatima’ who later gave it to the Crime Branch.

According to media reports, the woman had written that she had seen Najeeb in a market in Aligarh. The letter further stated that Najeeb sought the woman’s help saying that he had been held captive by some people and had somehow managed to escape. However, by the time the woman could call for help, Najeeb had disappeared, reportedly.

The woman had also mentioned an address in the letter where she could be contacted. However, according to media reports, when the police reached the address, no one could be found.

Reportedly, the letter didn’t mention anything about the village where Najeeb was locked up or about a ransom amount.

The police suspect that it was a prank. However, according to media sources, they are going to find out the location from where the letter was dispatched to be sent to the JNU hostel.

Only recently, the CCTV footage sought by Delhi Police from the Jamia authorities in connection with the disappearance of JNU student Najeeb Ahmed had been found erased as the authorities store a day’s clips for one month, prompting the probe team to seek help from Forensic Science Laboratory (FSL) to retrieve the images.

Meanwhile, the reward amount for providing information on Najeeb’s whereabouts has been increased from Rs 2 lakh to Rs 5 lakh owing to the “sensitivity” of the matter.

Najeeb went missing on October 15 following an on-campus scuffle allegedly with ABVP members the night before.

The case was last week transferred from South District Police to Crime Branch in order to have a “fresh look” at the case.

Comments

Ansari
 - 
Sunday, 20 Nov 2016

and same time Modi anounced Note Ban....there was Shariah issue ...Modi banned Notes ....there was other scams ...Modi same time Bans Notes....WOw what double Mind

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
April 30,2020

Bengaluru, Apr 30: Shares of Glenmark Pharmaceuticals Ltd rose almost 9% on Thursday after the Indian drugmaker got an approval to conduct clinical trials with antiviral drug favipiravir, seen as a potential treatment for COVID-19.

Favipiravir, manufactured under the brand name Avigan by a unit of Japan's Fujifilm Holdings Corp and approved for use as an anti-flu drug in the Asian island country in 2014, has been effective, with no obvious side-effects, in helping coronavirus patients recover, a Chinese official told reporters at a news conference last month.

"After having successfully developed the API and the formulations ... Glenmark is all geared to immediately begin clinical trials on favipiravir on COVID-19 patients in India," Sushrut Kulkarni, executive vice-president for Global R&D, Glenmark Pharmaceuticals, said in a statement. 

The Drug Controller General of India, the country's drug regulator, did not immediately respond to Reuters request for comment.

On Wednesday, another Indian pharmaceutical company, Strides Pharma Science Ltd, said it had developed and commercialized favipiravir antiviral tablets, and had applied to Indian drug authorities to start trials.

Shares of Mumbai-based Glenmark Pharmaceuticals, which rose as much as 8.9% to 359 rupees ($4.78), was trading up 5.9%, as of 0407 GMT.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
April 29,2020

New Delhi, Apr 29: India's tally of COVID-19 cases has reached 31,332, said the Union Ministry of Health and Family Welfare on Wednesday. With 73 more deaths reported, the number of deaths due to coronavirus in the country breached the 1,000 mark and stood at 1,007.

The tally is inclusive of 22,629 active coronavirus cases, 7,695 patients who have been cured/discharged and one patient migrated.

According to the Ministry, Maharashtra has the most number of COVID-19 cases with 9,318 cases of which, 1,388 patients have been cured/discharged while 400 patients have succumbed to the virus.

Gujarat has the second-highest number of positive cases in the country with 3744 cases including 434 patients cured/discharged and 181 deaths.

Delhi's tally stands at 3314 cases of which, 1078 patients have recovered while 54 patients have succumbed to the virus.

Madhya Pradesh has a total of 2387 positive cases including 377 patients recovered/discharged and 120 fatalities.

Meanwhile, Goa (seven cases; all seven recovered), Arunachal Pradesh (one case; now recovered), Manipur (two cases; both recovered), Tripura (two cases; both recovered) have reported no new cases of COVID-19.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
February 4,2020

The government suspended all the India-bound air travel from China and has declared all visas 'invalid', on Monday, due to the rapid escalation of cases of novel coronavirus outbreak which originated in Wuhan.

"Embassy and our Consulates have been receiving several queries from Chinese citizens as well as other foreign nationals, who are based out of China or visited China in the last 2 weeks, as to whether they can use their valid single/multiple entry visas to travel to India," tweeted the Embassy of India in Beijing, China.

"It is clarified that existing visas are no longer valid. Intending visitors to India should contact the Indian Embassy in Beijing ([email protected]) or the Consulates in Shanghai ([email protected]) and Guangzhou ([email protected]) to apply afresh for an Indian visa," it said.

Further, regarding the validity of visas, the embassy said, "Indian Visa Application Centres (http://blsindia-china.com) in these cities may also be contacted in this regard. Visa Section of the Embassy/Consulates of India in China can be contacted to ascertain the validity of visa before undertaking any visit to India."

"All those who are already in India (with regular or e-visa) and had traveled from China after January 15 are requested to contact the hotline number of Ministry of Health and Family Welfare of Government of India (+91-11-23978046 and email: [email protected])," the embassy said.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.